Advances in the Field of Biofilm-Associated Musculoskeletal Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".
Deadline for manuscript submissions: 5 June 2025 | Viewed by 824
Special Issue Editor
2. Department of Microbiology, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK
Interests: intensive care; orthospinal related infections; biomarkers of sepsis; clinical deterioration; antimicrobial stewardship and infection prevention
Special Issue Information
Dear Colleagues,
The Special Issue aims to cover a range of novel advances (original research and reviews) on the following topics:
1) Anti-biofilm active agents in biofilm-associated musculoskeletal infections;
2) Are fracture-related infections biofilm-associated infections?
3) The relation between MBEC and MIC when treating biofilm-associated musculoskeletal infections;
4) Mycobacterial-associated musculoskeletal infections and implant-related infections: what is new?
5) Are biofilm-associated musculoskeletal infections different between high-income countries and low-income countries?
6) Updates on phage therapy in biofilm-associated musculoskeletal infections.
Dr. Kordo Saeed
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- musculoskeletal infections
- biofilm-associated
- mycobacterial-associated
- implant-related infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
